Home > Insider Trading > Filing (0001181431-11-048283)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1486519	Brannon David Johnston	C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-01	2,000	$5.60	8,000	No	4	M	Direct
Common Stock	Disposition	2011-09-01	2,000	$16.87	6,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employye Stock Option (right-to-buy)	Disposition	2011-09-01	2,000	$0.00	2,000	$5.60

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
170,000		2017-10-31	No	4	M	Direct

Footnotes

The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2011.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.67 to $16.97, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
The option vested as to 25% of the shares on October 31, 2008 and as to an additional 1/48 of the shares per month thereafter.